ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2026; 16(5): 278-285


Development of alginate bead-based three-dimensional culture of hepatocellular carcinoma cells with cytotoxicity assessment of thymoquinone

Abdelkader Hassani, Samir Chadli, Mohamed Atoui, Billel Smili, Hamad Ali Hamad, Zakaria Boual, Abd Almonem Doolaanea.



Abstract
Download PDF Post

Alginate bead-based three-dimensional (3D) culture provides a biomimetic environment that closely mimics in vivo conditions, thereby effectively maintaining the morphology and cellular connections of HepG2 cells. During the bead formation process, an electrospray system was used to vary the voltage provided to the nozzle to control the size and homogeneity of the beads. Alginate beads formed at 3 kV exhibited the highest cell viability, exceeding 80%, with an average bead diameter of approximately 2–3 mm. Cytotoxicity testing using Thymoquinone (TQ) revealed that HepG2 cells cultured in a 3D alginate system exhibited significantly greater resistance compared to those cultured in a two-dimensional (2D) monolayer. The concentration of TQ required to inhibit 50% of cell viability (IC50) was 916 μg/ml in 3D culture, whereas only 384 μg/ml was required in 2D culture. The 3D alginate bead model enhances the accuracy of drug sensitivity evaluation and more closely mimics in vivo tumor behavior. This approach offers a viable alternative to conventional cell culture models and may reduce the need for animal testing in preclinical research.

Key words: Alginate beads; HepG2 cell lines; Three-dimensional culture; Thymoquinone; Electrospray technique; Cytotoxicity assay.







Bibliomed Article Statistics

11
R
E
A
D
S

3
D
O
W
N
L
O
A
D
S
04
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.